Triumvira Immunologics Appoints Life Sciences Industry Leader Robert Williamson as President and Chief Business Officer
Triumvira Immunologics, Inc. (“Triumvira”), a clinical-stage company developing novel, targeted autologous and allogeneic T cell therapeutics that co-opt the natural biology of T cells to treat patients with cancer, today announced the appointment of Robert Williamson as President and Chief Business Officer ...
United States Paul Lammers Robert Williamson Pomona College Eos Biotechnology Inc Triumvira Immunologics Inc
Source: pharmiweb.com